← Back to Search

rPMS for Stroke Rehabilitation

N/A

Recruiting

Led By Sangeetha Madhavan, PhD

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosed mono-hemispheric stroke

Participants must demonstrate adequate cognitive abilities to be able to follow the protocol (21>MMSE).

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 60 minutes after the stimulation

Awards & highlights

Study Summary

This trial will examine the effects of rPMS on motor skill performance after stroke. It may lead to better rehabilitation techniques, aiding those affected by stroke.

Who is the study for?

This trial is for individuals who had a stroke more than 3 months ago, can follow instructions (MMSE score over 21), and have a stroke that affected only one side of the brain. It's not for those with brainstem or cerebellum damage, other conditions like Alzheimer's or Parkinson's, or complete paralysis preventing motor tasks.Check my eligibility

What is being tested?

The study tests repetitive peripheral magnetic stimulation (rPMS) as a sensory-based priming technique to enhance motor skill performance in people who've had a stroke. Participants will be compared to those receiving sham (fake) treatment.See study design

What are the potential side effects?

While specific side effects are not detailed here, rPMS is generally considered safe but may include discomfort at the stimulation site, mild headaches, or temporary changes in skin sensation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I had a stroke affecting one side of my brain.

Select...

I can follow study instructions well.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 60 minutes after the stimulation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~60 minutes after the stimulation

This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 minutes after the stimulation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Motor skill performance

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Sensory-based primingExperimental Treatment1 Intervention

Participants will receive rPMS at 10% above motor threshold with the coil placed on the Tibialis Anterior muscle belly. rPMS parameters will be: 40 trains, intermittently (3) seconds on, (19) seconds off, with an intensity ~10% above motor threshold.

Group II: Sham PrimingPlacebo Group1 Intervention

Participants will receive sham rPMS at a very low intensity with the coil placed on the dorsal part of the foot. rPMS parameters will be: 40 trains, intermittently (3) seconds on, (19) seconds off, with an intensity at 5% of maximum stimulator output.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor

609 Previous Clinical Trials

1,559,209 Total Patients Enrolled

18 Trials studying Stroke

2,151 Patients Enrolled for Stroke

Sangeetha Madhavan, PhDPrincipal InvestigatorUniversity of Illinois at Chicago

Media Library

Repetitive Peripheral Magnetic Stimulation (rPMS) Clinical Trial Eligibility Overview. Trial Name: NCT05833490 — N/A

Stroke Research Study Groups: Sensory-based priming, Sham Priming

Stroke Clinical Trial 2023: Repetitive Peripheral Magnetic Stimulation (rPMS) Highlights & Side Effects. Trial Name: NCT05833490 — N/A

Repetitive Peripheral Magnetic Stimulation (rPMS) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05833490 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any slots still open to join this research project?

"Affirmative, the information on clinicaltrials.gov reveals that this trial is actively enrolling subjects. The first announcement of this study was posted on April 24th 2023 and its most recent update was made one day later. A total of 100 patients are needed for enrollment at a single location."

Answered by AI

What is the scope of recruitment for this trial?

"That is correct. As seen on clinicaltrials.gov, this medical trial went live on April 24th 2023 and has subsequently been updated once since then. 100 patients are being sought from one research centre for the duration of the study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Effect of rPMS on Motor Skill Performance in Persons With a Stroke.

Sangeetha Madhavan 2023. "The Effect of rPMS on Motor Skill Performance in Persons With a Stroke.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05833490.